Twenty years of renal transplantation at Ohio State University: The results of five eras of immunosuppression

American Journal of Surgery

Volumn 186, Issue 3, 2003, Pages 306-311

  Ferguson, Ronald M ^a   Henry, Mitchell L ^a   Elkhammas, Elmahdi A ^a   Davies, Elizabeth A ^a   Bumgardner, Ginny L ^a   Pelletier, Ronald P ^a   Rajab, Amer ^a  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Immunosuppression; Renal transplantation outcome

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; RAPIMMUNE;

AVASCULAR NECROSIS; CATARACT; FRACTURE; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; KIDNEY TRANSPLANTATION; MOOD DISORDER; OSTEOPOROSIS; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; TREATMENT OUTCOME; UNITED STATES; WEIGHT GAIN; ARTICLE; HISTORY; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; LENGTH OF STAY; MEDICAL SCHOOL; SURVIVAL;

GRAFT REJECTION; GRAFT SURVIVAL; HISTORY, 20TH CENTURY; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LENGTH OF STAY; OHIO; SCHOOLS, MEDICAL; SURVIVAL ANALYSIS;

EID: 0141501156     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9610(03)00219-8     Document Type: Note

References (13)

1. Schwartz R.S., Dameshek W. Drug induced immunologic tolerance. Nature. 183:1959;1862.
2. Calne R.Y., Alexander G.P.J., Murray J.E. A study of the effects of drugs in prolonging survival of homologous renal transplants in dogs. Ann NY Acad Sci. 99:1962;743.
3. Marchioro T.L., Axtell H.K., LaVia M.F., et al. The role of adrenocorticosteroids and reversing established homographed rejection. Surgery. 55:1964;412.
4. Woodruff M.F. Immunologic properties of anti lymphocytes serum. J Clin Pathol. 20:1967;466.
5. Monaco A.P., Abbott W.M., Othersen H.B., et al. Anti serum to lymphocytes prolonged survival of canine renal allografts. Science. 153:1966;1264-1267.
6. Stinson E.B., Dong E., Bieber C.P., et al. Cardiac transplantation in man. I. Early rejection. JAMA. 207:1969;2233-2247.
7. Calne R.Y., White D.J.G., Thorin S. Cyclosporine A in patients receiving renal allografts from cadaver donors. Lancet. 2:1978;1323-1327.
8. Starzl T.E., Weil R., Iwatsuki S. The use of cyclosporine A and prednisone in cadaver transplantation. Surg Gynecol Obstet. 151:1980;17-26.
9. Ferguson R.M., Sommer B.G. Cyclosporine (CsA) in renal transplantation a single institution experience. Am J Kidney Dis Surg. 5:1985;296-306.
10. Ferguson R.M. Acute rejection episodes - best predictor of long-term primary cadaveric renal transplant survival. Clin Transplant. 8:1994;328-331.
11. Tesi R.J., Elkhammas E.A., Henry M.L., Ferguson R.M. OKT3 for primary therapy of first rejection episode in kidney transplants. Transplantation. 55:1993;1023-1029.
12. Ferguson R.M. Aspects of allograft rejection, II. Risk factors in renal allograft rejection. Transplant Rev. 27:1995;121-126.
13. Pelletier R.P., Cosio C.G., Henry M.L., et al. Rejection following renal transplantation. Evidence that severity is the best predictor of subsequent graft survival time. Clin Transplant. 12:1998;543-552.